Combinatorial Screening of Peptides, Specific Ligands of Death Receptor DR5
Sign Up to like & getrecommendations! Published in 2017 at "Bulletin of Experimental Biology and Medicine"
DOI: 10.1007/s10517-017-3809-8
Abstract: Death receptors, in particular DR5, are highly attractive targets of antitumor therapy. The major limitation to application of natural death receptor ligands (TRAIL) is their non-specific cytotoxicity against normal cells. Since TRAIL can also bind… read more here.
Keywords: death; combinatorial screening; death receptor; screening peptides ... See more keywords